The short answer: PrEP (pills or shots) greatly reduces the chance of getting HIV, but it does not prevent other STIs or pregnancy. DoxyPEP (a dose of doxycycline after sex) can help prevent chlamydia, syphilis, and gonorrhea in the groups where it has been studied — and it does not prevent HIV, herpes, HPV, mpox, pubic lice ("crabs"), or pregnancy. People who use both tools still need condoms when they fit the plan, vaccines where available, and regular multi-site STI testing.

If you are on PrEP, DoxyPEP, or both, and you still picked up gonorrhea, herpes, crabs, or another infection, you did not "fail" prevention. You ran into the limits of what each medicine is designed to do. Below is a clear map of what each tool covers, what neither covers, how often to test if you use both, and how condoms and vaccines fit — based on CDC guidance, not guesswork.

What does PrEP protect against?

According to the CDC's page on Preventing HIV with PrEP, PrEP (pre-exposure prophylaxis) is medicine — pills or shots — that reduces your chance of getting HIV from sex or injection drug use. It is for adults and adolescents who do not have HIV and who may be exposed to HIV.

The same CDC page states this plainly: "PrEP reduces the chance of getting HIV but doesn't prevent other STIs or pregnancy. Condoms can help prevent certain other STIs and pregnancy." In other words, PrEP is an HIV-prevention tool. It is not a general STI shield.

Injectable PrEP options (including twice-yearly shots) still target HIV only. For what daily life with a long-acting PrEP shot can feel like, see our post on Yeztugo side effects and injection-site lumps. Talk with a licensed clinician about which PrEP form, if any, fits your situation.

What does DoxyPEP protect against?

DoxyPEP (doxycycline post-exposure prophylaxis) is different. It is an antibiotic taken after sex, not an HIV medicine. The CDC's consumer page on Preventing STIs with Doxy PEP says taking doxycycline within 72 hours after sex can help some people reduce the chances of getting certain bacterial STIs. That page also states: "Doxy PEP can only help prevent chlamydia, syphilis, and gonorrhea. It does not prevent other common STIs, like HIV, or herpes."

CDC's 2024 clinical guidelines in the MMWR Recommendations and Reports summarize three large randomized trials among MSM and transgender women: 200 mg of doxycycline taken within 72 hours after sex reduced syphilis and chlamydia by more than 70% and gonococcal infections by about 50%. CDC recommends that clinicians counsel gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) who had syphilis, chlamydia, or gonorrhea in the past 12 months that DoxyPEP can be used, and offer a prescription after shared decision-making.

How clinicians typically prescribe it, per CDC: 200 mg of doxycycline as soon as possible within 72 hours after anal, oral, or vaginal/front-hole sex, and not more than one 200 mg dose in any 24-hour period, no matter how many times someone has sex that day. That is what CDC says providers prescribe — it is not personal medical advice for you. Your clinician decides whether DoxyPEP is appropriate, which formulation to use, and how many doses to supply until the next visit.

Data outside those study populations are limited. The MMWR notes a Kenya trial among cisgender women found no significant reduction in bacterial STIs, with evidence of low adherence; CDC says no recommendation can be given at this time for cisgender women, cisgender heterosexual men, transgender men, and other queer and nonbinary people assigned female at birth. Shared decision-making with a clinician still matters. For real-world syphilis and chlamydia trends after DoxyPEP rollout, see our news post on a nationwide study linking DoxyPEP to fewer syphilis cases.

What do PrEP and DoxyPEP not protect against?

Neither medicine is a complete sexual-health plan. Putting the CDC statements side by side:

• HIV: Covered by PrEP (when taken as prescribed). Not prevented by DoxyPEP.
• Chlamydia and syphilis: DoxyPEP can help prevent these in the populations where trials showed benefit. PrEP does not prevent them.
• Gonorrhea: DoxyPEP reduced gonococcal infections by about 50% in the MSM/TGW trials summarized by CDC — helpful, not perfect. PrEP does not prevent gonorrhea. Drug-resistant gonorrhea remains an urgent concern; see our post on the CDC calling drug-resistant gonorrhea an urgent threat.
• Herpes (HSV-1 and HSV-2): Not prevented by PrEP or DoxyPEP. CDC's DoxyPEP page names herpes explicitly as not covered.
• HPV: Not prevented by PrEP or DoxyPEP. Vaccination (when eligible) and condoms are the tools that address HPV risk — ask a clinician.
• Mpox: Not prevented by PrEP or DoxyPEP. CDC's DoxyPEP page points people to the two-dose mpox vaccine and testing if symptoms appear.
• Pubic lice ("crabs") and other parasites: Not prevented by PrEP or DoxyPEP. These are not bacterial STIs those medicines target.
• Pregnancy: PrEP does not prevent pregnancy. DoxyPEP is not birth control. Condoms and other contraception remain relevant if pregnancy is a concern.
• Viral hepatitis and other infections: CDC's DoxyPEP page also flags hepatitis A and B vaccination, hepatitis testing, and infections such as shigella as part of broader sexual-health care — none of which PrEP or DoxyPEP replace.

DoxyPEP is also not a vaccine and not a treatment for an STI you already have. CDC notes the DoxyPEP dose is not strong enough to treat an existing infection; if you test positive, you need the treatment regimen your clinician recommends.

How often should you get tested if you use PrEP, DoxyPEP, or both?

Using both tools does not mean you can skip screening. CDC's MMWR guidelines say people prescribed DoxyPEP should get bacterial STI testing at anatomic sites of exposure at baseline and every 3–6 months, with ongoing need for DoxyPEP reassessed on the same schedule. HIV screening for people without HIV should follow current recommendations. People on PrEP also need routine HIV tests and clinic follow-up so the medicine can be continued safely.

In practice, that often means multi-site testing (for example throat, rectum, and urine/genital sites when those exposures happen) — not only a urine test. Talk with your clinician about which sites match your sex practices. Our guide to how often to get tested for STDs walks through screening rhythms in more detail.

How do condoms, vaccines, and layering fit?

CDC frames both PrEP and DoxyPEP inside a broader plan:

• Condoms help prevent certain other STIs and pregnancy (CDC PrEP page) and remain useful even when someone uses biomedical prevention.
• Vaccines that may apply include HPV, hepatitis A and B, and mpox — based on age, risk, and prior vaccination. Ask a clinician what you still need.
• HIV treatment as prevention (U=U) matters when a partner is living with HIV and has a sustained undetectable viral load — that is separate from PrEP and DoxyPEP, and complementary.
• Layering means matching tools to risks instead of expecting one pill to do everything. Our related post on layering condoms, antivirals, and PrEP focuses on how those layers stack; this article is specifically about the gaps each layer leaves open.

Catching an STI while on PrEP or DoxyPEP is information, not a moral verdict. It is a signal to treat what you have, tell partners who need to know, and adjust the mix of tools with a clinician who knows your life.

FAQ

If I am on PrEP and DoxyPEP, can I skip condoms?

That is a personal decision to make with accurate information and, ideally, a clinician. CDC is clear that PrEP does not prevent other STIs or pregnancy, and DoxyPEP only helps with chlamydia, syphilis, and (partially) gonorrhea. Condoms still reduce risk for infections and outcomes those medicines miss. Many people use different combinations with different partners; the goal is informed choice, not shame.

Does DoxyPEP prevent herpes or HPV?

No. CDC states DoxyPEP does not prevent other common STIs such as HIV or herpes. HPV is likewise outside what DoxyPEP is for. Vaccination (for HPV, when eligible) and other prevention steps are separate conversations with a clinician.

Can I still get gonorrhea on DoxyPEP?

Yes. In the trials CDC summarizes, DoxyPEP cut gonococcal infections by about half — not to zero — and resistant gonorrhea is an ongoing public-health problem. Testing and partner treatment still matter.

Does PrEP protect my partners from other STIs?

PrEP protects the person taking it from acquiring HIV. It does not prevent the PrEP user from getting or passing other STIs. Partners still benefit from testing, treatment, condoms when chosen, vaccines, and — if a partner has HIV — effective HIV treatment.

Is DoxyPEP the same as PEP for HIV?

No. HIV PEP is a short course of antiretroviral medicine started after a possible HIV exposure. DoxyPEP is doxycycline used after sex to reduce risk of certain bacterial STIs. They are different drugs for different infections. A clinician can explain which, if either, applies after a specific exposure.

Who is DoxyPEP recommended for?

CDC recommends that clinicians discuss DoxyPEP with gay, bisexual, and other MSM and with transgender women who had chlamydia, syphilis, or gonorrhea in the past 12 months, and offer it through shared decision-making. Evidence is insufficient for a CDC recommendation in other groups at this time; ask a clinician about your own situation.

The bottom line

PrEP is powerful against HIV and silent against most other STIs. DoxyPEP can meaningfully lower chlamydia and syphilis risk (and partly gonorrhea risk) in the groups where it has been studied, and it does nothing against HIV, herpes, HPV, mpox, or crabs. Using both is smart for many people — and still incomplete without testing, vaccines where indicated, and condoms when they fit your plan. Bring questions to a licensed health care provider; do not start, stop, or share someone else's antibiotics on your own. And if you want a dating space built for people navigating HIV, herpes, and other STIs with honesty, visit MeetPositives.

Sources

• Centers for Disease Control and Prevention. "Preventing HIV with PrEP." https://www.cdc.gov/hiv/prevention/prep.html
• Centers for Disease Control and Prevention. "Preventing STIs with Doxy PEP." https://www.cdc.gov/sti/prevention/doxy-pep.html
• Centers for Disease Control and Prevention. "CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024." MMWR Recommendations and Reports, 73(RR-2):1–8. https://www.cdc.gov/mmwr/volumes/73/rr/rr7302a1.htm

This article is for general information only and is not medical advice. It does not create a doctor-patient relationship. Talk with a licensed health care provider about your own situation.